TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Arrive AI Inc. (ARAI)

Technology Scientific & Technical Instruments
0.24 $
-2.2% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

symbol.quality_heading

Substance risk

We found at least one documented issue that threatens the company itself — regardless of how the stock is currently valued.

The auditor's going-concern qualification on the 2025 annual report is expressly described as unresolved in the quarterly report for March 31, 2026: at roughly $1 million of cash burn per month against roughly $7.1 million of liquidity (May 12, 2026), the cash on hand does not cover four quarters, and more than 90 percent of the $113,250 in revenue comes from a single customer. On top of that come a restatement of the Q2 and Q3 2025 quarterly reports, acknowledged material weaknesses in internal control, and two open Nasdaq deadlines (November 30, 2026 and January 19, 2027) — the survival of the company itself is therefore in question. The decision is yours.

symbol.quality_note

Read the Full Deep Dive
Arrive AI: "AI" in the Name, $113,250 in Revenue — and Financing That Eats the Stock

A smart mailbox for drones and delivery robots, renamed three times — most recently to "Arrive AI" — and listed on Nasdaq in May 2025 through a direct listing. The annual report behind it: $113,250 in revenue, more than 90 percent of it from a single customer, a $12.8 million net loss and a going-concern warning from the auditor. It is all financed through convertible pre-paid purchases from Streeterville Capital that turn into ever more shares at ever lower prices: 34.2 million shares at the end of 2025, 51.9 million just four and a half months later. Add three Nasdaq deficiency notices within four months. Not investment advice — just the question of what is left of the name once you read the filings.

Read the analysis

Stock Watch

This analysis is as of July 27, 2026. Stock Watch will tell you what's changed at ARAI since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 11 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Trading Day

Previous Close
0.24$
Open
0.24$
Day High
0.29$
Day Low
0.22$
Volume
2,102,879shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
0.24 $ 7.90 $
07/29/2026 07/31/2025

Current price 0.24 $ — 0% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
0.01$B
Shares Outstanding
52Mio.
Float
43.2%
Beta

Performance

Perf. 1M
-38.50%
Perf. 3M
-73.50%
Perf. 6M
-93.60%
YTD Performance (%)
-83.30%
52-Week-High Distance
-97.0%
Perf. 1Y
-97.03%
Perf. 5Y
-96.88%
Perf. Since Inception
-98.23%

Technical Indicators

MA 38 Days
0.39$
MA 50 Days
0.45$
MA 200 Days
1.90$
RSI (14)
23.5
Volatility 30 Days
77.8%
Volatility 250 Days
144.3%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
Forward P/E
0.0
PEG
P/B
4.8
P/S
110.0
EV/EBITDA
0.0
Price/FCF

Profitability

Gross Margin
100.0%
EBIT Margin
Net Margin
0.0%
Return on Equity
-398.1%
Return on Assets
-68.7%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
3.7
warning zone
Altman Z″
-10.15
Piotroski
3 out of 9

Growth

Sales Growth Last Quarter
0.00%
EPS Growth Last Quarter
0.00%
Sales Growth (Year)
Forward Sales Growth
650.00%
Forward EPS Growth

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
4
RS Rating
1
EPS Rating
42
Piotroski
3 out of 9
Fundamental Rating
D (37 out of 100)
warning zone
Altman Z″
-10.15

AI Rating

Sells AI

Das einzige Produkt — die ALM-Plattform mit dem Arrive-Point-Netz — wird im 10-K ausdrücklich mit „AI Services“ als Erlössäule beschrieben und über laufende Abos verkauft (113.250 $ Umsatz 2025, 14.925 $ in Q1 2026); die KI-Datenmonetarisierung selbst ist laut 10-Q noch im Aufbau (ML erst für die Stationsgenerationen AP4/AP5 geplant).

View the full file — quotes, sources, reviewed filings
„Our integrated ALM Platform combines a physical Arrive Point™ Network (delivered as Network-as-a-Service), an ALM Marketplace for dynamic scheduling and transactional optimization and AI Services for data-driven insights and automation."

Unsere integrierte ALM-Plattform verbindet ein physisches Arrive-Point™-Netz (bereitgestellt als Network-as-a-Service), einen ALM-Marktplatz für dynamische Terminierung und Transaktionsoptimierung und AI Services für datengetriebene Erkenntnisse und Automatisierung.

10-K · 2026-04-15 · View SEC filing
„Data monetization via models and insights generated by machine learning and artificial intelligence (“ML” and “AI”)."

Datenmonetarisierung über Modelle und Erkenntnisse, die durch maschinelles Lernen und künstliche Intelligenz („ML“ und „AI“) erzeugt werden.

10-Q · 2026-05-15 · View SEC filing
„Our mission is to connect these systems through a universal ALM network of Arrive Points™—smart lockers and mini-cross-docks—powered by an AI-driven ALM platform."

Unsere Mission ist es, diese Systeme über ein universelles ALM-Netz aus Arrive Points™ — smarte Schließfächer und Mini-Umschlagpunkte — zu verbinden, angetrieben von einer KI-getriebenen ALM-Plattform.

10-Q · 2026-05-15 · View SEC filing

Filings Reviewed: 10-K 2026-04-15 · 10-Q 2026-05-15 · 8-K 2026-07-24 · 424B5 2026-06-12 · 8-K 2026-06-05 · 8-K 2026-05-18

Rated on July 27, 2026 · How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 0.24 $
Price Target (average) 5.00 $

The price target sits 1,983.3% above the current price.

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Next Reporting Date

13. Aug 2026 · before the open · Q2 2026
Expected Earnings per Share
-0.09 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 0.0 $M Q4 2025: Q1 · 0.0 $M Q1 2025: Q2 · 0.1 $M Q2 2025: Q3 · 0.0 $M Q3 2025: Q4 · 0.0 $M Q4 2026: Q1 · 0.0 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.03 0 0 0
2025: Q1 -0.04 0 -1 -1
2025: Q2 -0.09 0 -5,153.80 -3 -3
2025: Q3 -0.04 0 -31,957.10 -1 -1
2025: Q4 -0.08 0 -26,146.70 -3 -4
2026: Q1 -0.12 0 -42,466.70 -3 -4
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Assessment: Opportunities & Risks

Product & patents

The idea is serious: smart delivery stations for the autonomous last mile, a patent portfolio granted since 2017 (nine U.S. patents plus international filings) and paying pilot customers from medical logistics (including Hancock Health). But the AI features are only planned for the AP4/AP5 station generations; in operation are pilot installations of the 3rd generation (per the 10-K, April 15, 2026).

Cash cushion & time bought

The company has bought itself time: $9.6 million net in January 2026, roughly $7.1 million of liquidity as of May 12, 2026, a standstill with Streeterville through December 31, 2026 and an at-the-market program of up to $15 million (June 12, 2026). At roughly $1 million of monthly burn (2025), that lasts into 2027 depending on the pace — then new money is needed at whatever prices prevail.

Revenue reality

$113,250 of revenue in 2025, $89,000 of it consulting and more than 90 percent from a single customer (Hancock Health, per the 10-K); Q1 2026: $14,925. The "AI Services" in the company name are so far future tense without revenue. Operating expenses 2025: $10.5 million — that mismatch is the core number of this stock.

Liquidity & going concern

Going-concern opinion from the auditor on the 2025 accounts; the 10-Q as of March 31, 2026 declares the doubt "not alleviated." Cash of $2.1 million at year-end 2025 against ~$1 million of monthly burn; the remaining ~$19 million of the facility requires a $100 million market capitalization — more than three times the filing anchor of ~$29 million (June 11, 2026).

Dilution & financing structure

Conversion at min(reference price; 90 percent of the lowest 10-day VWAP, $0.25 floor): share count up from 34.2 million (December 31, 2025) to 51.9 million (May 15, 2026), +52 percent; per the 10-Q, another +63 percent possible. Add 2,937,500 pre-delivery shares for $588 and an ATM program that opens the next dilution source. The stock fell along the conversion staircase from $2.25 (January 26) to ~$0.53 (April).

Listing & reporting quality

Three Nasdaq notices within four months (MVPHS March 31, cured; minimum bid price, deadline November 30, 2026; MVPHS again, deadline January 19, 2027). Restatement of the Q2+Q3 2025 10-Qs over a misbooked conversion derivative (8-K Item 4.02, April 14, 2026) and admitted material weaknesses — of all places, in the accounting for the financing the company depends on.

Bottom Line

Arrive AI is the label trap in its purest form: "AI" in the name, a serious product idea with a real patent portfolio — and underneath, filings that document a fight for survival: $113,250 of annual revenue (more than 90 percent from one customer) against a $12.8 million loss, a going-concern warning that the quarterly report calls "not alleviated," financing that raised the share count by 52 percent in four and a half months, and three Nasdaq notices with deadlines of November 30, 2026 and January 19, 2027. Whoever buys is buying an option on survival — not AI infrastructure with substance. Not investment advice.

Worth Noting:
  • The stock landed on our desk via the SEC's fresh filings (8-K of July 24, 2026, second MVPHS notice from Nasdaq) — not via a metrics scanner: the company was not in our database before this research. No meaningful P/E or P/S; classic multiples mislead at this revenue level.
  • The market capitalization from the market-data feed deviated by more than 20 percent from the filing anchor and was not used; all price and valuation figures come from the filings ($13.00 fair value 01–05/2025; $2.63 on December 31, 2025; $0.797 on March 31, 2026; $0.56 on June 11, 2026 per the 424B5; market value ~$29 million = 51,859,347 × $0.56). Analyses are evergreen; daily prices are not a buy argument.
  • Not to be confused: Arrive AI (ARAI, delivery infrastructure out of Indiana) has nothing to do with Atai Life Sciences (ATAI, biotech). The name history DRONEDEK → Arrive Technology → Arrive AI is documented in the 10-K; the 1-for-4 reverse split of November 25, 2024 predates the listing, and all share counts are retroactively adjusted.

About the Company

Arrive AI Inc., ein Technologieunternehmen, entwirft und implementiert ein kommerziell tragfähiges System aus smartem Briefkasten und Plattform in den USA.

Employees43
HeadquartersFishers, IN
Websitearriveai.com
IPO Date15. May 2025

Management

Management
Name Title Birth Year
Daniel Steven O'Toole Founder, CEO & Chairman 1965
Todd Pepmeier Chief Financial Officer 1975
Mark D. Hamm COO & Director 1967
John Ritchison Attorney, Secretary, General Counsel & Director 1951
Neerav Shah Chief Strategy Officer & Director 1973
Kylie Conway Senior Marketing & Communications Manager
Ian Geise Head of Commercialization 1972
Lora O'Toole Vice President of Business Development 2000

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?